These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9157813)

  • 21. Drug-resistant Streptococcus pneumoniae.
    Redondo E
    N Engl J Med; 1996 Jan; 334(1):53; author reply 54. PubMed ID: 7494575
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pneumococcal meningitis in children--9 1/2-year-experience at Szent László Hospital, Budapest, Hungary].
    Ivády B; Liptai Z; Ujhelyi E; Balázs G
    Ideggyogy Sz; 2008 Nov; 61(11-12):385-90. PubMed ID: 19070313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus.
    Asensi F; Pérez-Tamarit D; Otero MC; Gallego M; Llanes S; Abadia C; Cantó E
    Pediatr Infect Dis J; 1989 Dec; 8(12):895. PubMed ID: 2626294
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasculitic presentation of staphylococcal meningitis.
    Bentley P; Qadri F; Wild EJ; Hirsch NP; Howard RS
    Arch Neurol; 2007 Dec; 64(12):1788-9. PubMed ID: 18071046
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pneumococcal meningitis mortality in children. Prognostic factors in a series of 73 cases].
    Thabet F; Tilouche S; Tabarki B; Amri F; Guediche MN; Sfar MT; Harbi A; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Apr; 14(4):334-7. PubMed ID: 17187969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pneumococcal meningitis].
    Amathieu R; Poilane I; Tual L
    Rev Prat; 2006 Sep; 56(14):1521. PubMed ID: 17139862
    [No Abstract]   [Full Text] [Related]  

  • 30. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region.
    Tzanakaki G; Mastrantonio P
    Int J Antimicrob Agents; 2007 Jun; 29(6):621-9. PubMed ID: 17368858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin-resistant pneumococcus.
    Klugman KP
    Clin Infect Dis; 2000 Aug; 31(2):626-7. PubMed ID: 10987743
    [No Abstract]   [Full Text] [Related]  

  • 32. [Community-acquired pneumococcal meningitis. Report of 11 cases].
    Martínez de la Iglesia J; Montero Pérez FJ
    Enferm Infecc Microbiol Clin; 1990 Oct; 8(8):532-3. PubMed ID: 2095276
    [No Abstract]   [Full Text] [Related]  

  • 33. Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better.
    Boisier P; Maïnassara HB; Sidikou F; Djibo S; Kairo KK; Chanteau S
    Vaccine; 2007 Sep; 25 Suppl 1():A24-9. PubMed ID: 17521784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prolonged postpneumococcal meningitis inflammatory syndrome].
    Thabet F; Tabarki B
    Med Mal Infect; 2007 Mar; 37(3):179-80. PubMed ID: 17276644
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
    Plakogiannis R; Nogid A
    Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients].
    Firat M; Ersoy Y; Eşel D; Bayraktar M; Caylan R; Durmaz R
    Mikrobiyol Bul; 2006 Jul; 40(3):169-77. PubMed ID: 17001845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Highly-resistant Streptococcus pneumoniae meningitis in Central America].
    Ulloa-Gutiérrez R; Avila-Agüero ML; Herrera ML; Herrera JF; Vargas A; Barton T
    An Pediatr (Barc); 2003 Apr; 58(4):396-7. PubMed ID: 12681193
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of a 5-day course of intramuscular ceftriaxone to eradicate Streptococcus pneumoniae from the middle ear.
    Anon JB; Ripple WL; Jacobs MR
    Pediatr Infect Dis J; 2006 Feb; 25(2):181-2. PubMed ID: 16462302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral ischaemia in the context of improving, steroid-treated pneumococcal meningitis.
    Rice CM; Ramamoorthi M; Renowden SA; Heywood P; Whone AL; Scolding NJ
    QJM; 2012 May; 105(5):473-5. PubMed ID: 21493690
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes following pneumococcal meningitis: room for improvement remains expansive.
    Fisk BA; Jackson WL
    Crit Care Med; 2006 Nov; 34(11):2853-5. PubMed ID: 17053574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.